Key result
Perceval sutureless aortic valve replacement yields a ~2% 30-day mortality rate with high procedural success.
Why the study?
The safety and performance of the Perceval sutureless valve in aortic valve replacement patients required evaluation through early clinical outcomes.
What are the 30-day clinical outcomes and safety of the Perceval sutureless valve in patients undergoing aortic valve replacement?
Cohort (n=139)
What are the 30-day clinical outcomes and safety of the Perceval sutureless valve in patients undergoing aortic valve replacement?
Early postoperative results indicate that the Perceval sutureless aortic valve is safe and has acceptable hemodynamic performance at 30 days.
Answers are grounded in this paper and cite their sources.
May support Perceval use in selected aortic cases; observational data leaves open need for randomized durability comparisons.
OBJECTIVE: The aim of this retrospective study is to evaluate the safety and performance of the Perceval sutureless valve in patients undergoing aortic valve replacement. We report the 30-day clinical outcomes of 139 patients. METHODS: From January 2014 to December 2016, 139 patients underwent sutureless aortic valve replacement. Their operation notes, National Adult Cardiac Surgery Database and perioperative transoesophageal echocardiography findings were studied retrospectively. RESULTS: Ninety-two patients underwent isolated aortic valve replacement (group A) with Perceval valve and 47 patients had combined procedures of aortic valve replacement and coronary artery bypass grafting (group B). The patients received a size S (n=23), M (n=39), L (n=42) or XL (n=35) prosthesis. Perceval valve was successfully implanted in 135 (97.1%) patients. Mean cross-clamping time and bypass time were 40 and 63 minutes for isolated cases, while 68 and 107 minutes for combined cases. Three (2.1%) patients died within 30 days. Four patients suffered stroke and 5 patients went into acute renal failure. Median intensive care unit and hospital stay was 2 and 8.5, respectively. Four valves were explanted due to significant paravalvular leak after surgery. Five patients had permanent pacemaker as a result of complete heart block and mean postoperative drainage was 295 mL for isolated case and 457 mL for combined cases. The mean gradient across Perceval valve was 12.5 mmHg while its effective orifice area was 1.5 cm2. CONCLUSION: Early postoperative results showed that Perceval valve is safe. Further follow up is needed to evaluate the long-term outcome with this bioprosthesis.
No takes yet. Share an insight, caveat, or question.
Mujtaba et al. (2018) conducted a cohort in Aortic valve replacement (n=139). Perceval sutureless aortic valve was evaluated on 30-day mortality. The Perceval sutureless aortic valve was successfully implanted in 97.1% of patients undergoing aortic valve replacement, with a 30-day mortality rate of 2.1%.
Synapse has enriched 10 related papers. Consider them for comparative context: